Acute changes in colonic PGE 2 levels as a biomarker of efficacy after treatment of the Pirc (F344/NTac-Apc am1137 ) rat with celecoxib
ConclusionsAcute changes in colonic mucosa PGE2 provided a rapid means of predicting long-term chemopreventive effects from celecoxib, and might be useful for screening of new COX-2 inhibitor compounds.
Source: Inflammation Research - Category: Research Source Type: research
More News: Cancer | Cancer & Oncology | Celebrex | Colon Cancer | Colorectal Cancer | Diets | Epithelial Cancer | Gastrointestinal Polyps | Genetics | Nutrition | Oral Cancer | Polyps | Research | Study